<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1">

<meta name="author" content="Andrew Bean, Sebastian Weber" />

<meta name="date" content="2019-11-15" />

<title>Guiding Oncology Dose-Escalation Trials</title>



<style type="text/css">code{white-space: pre;}</style>
<style type="text/css" data-origin="pandoc">
a.sourceLine { display: inline-block; line-height: 1.25; }
a.sourceLine { pointer-events: none; color: inherit; text-decoration: inherit; }
a.sourceLine:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode { white-space: pre; position: relative; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
code.sourceCode { white-space: pre-wrap; }
a.sourceLine { text-indent: -1em; padding-left: 1em; }
}
pre.numberSource a.sourceLine
  { position: relative; left: -4em; }
pre.numberSource a.sourceLine::before
  { content: attr(title);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; pointer-events: all; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {  }
@media screen {
a.sourceLine::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */

</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    for (var j = 0; j < rules.length; j++) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") continue;
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') continue;
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>



<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#header {
text-align: center;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; }  code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Guiding Oncology Dose-Escalation Trials</h1>
<h4 class="author">Andrew Bean, Sebastian Weber</h4>
<h4 class="date">2019-11-15</h4>



<!--
%\VignetteEngine{knitr::rmarkdown}
%\VignetteIndexEntry{Guiding Oncology Dose-Escalation Trials}
-->
<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>The <code>OncoBayes2</code> package provides flexible functions for Bayesian meta-analytic modeling of the incidence of Dose Limiting Toxicities (DLTs) by dose level, under treatment regimes involving any number of combination partners. Such models may be used to support dose-escalation decisions and estimation of the Maximum Tolerated Dose (MTD) in adaptive Bayesian dose-escalation designs.</p>
<p>The package supports incorporation of historical data through a Meta-Analytic-Combined (MAC) framework [1], which stratifies these heterogeneous sources of information through a hierarchical model. Additionally, it allows the use of EXchangeable/Non-EXchangeable (EX/NEX) priors to manage the amount of information-sharing across subgroups of historical and/or concurrent sources of data.</p>
</div>
<div id="example-use-case" class="section level2">
<h2>Example use-case</h2>
<p>Consider the application described in Section 3.2 of [1], in which the risk of DLT is to be studied as a function of dose for two drugs, drug A and drug B. Historical information on the toxicity profiles of these two drugs is available from single agent trials <code>trial_A</code> and <code>trial_B</code>. The historical data for this example is available in an internal data set.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb1-1" title="1"><span class="kw">kable</span>(hist_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
<th align="right">drug_B</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0.0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0.0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0.0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0.0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">33.3</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">50.0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">100.0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">200.0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">15</td>
<td align="right">0</td>
<td align="right">400.0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">20</td>
<td align="right">2</td>
<td align="right">800.0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">17</td>
<td align="right">4</td>
<td align="right">1120.0</td>
</tr>
</tbody>
</table>
<p>The objective is to aid dosing and dose-escalation decisions in a future trial, <code>trial_AB</code>, in which the drugs will be combined. Additionally, another investigator-initiated trial <code>IIT</code> will study the same combination concurrently. Note that these as-yet-unobserved sources of data are included in the input data as unobserved factor levels. This mechanism allows us to specify a joint meta-analytic prior for all four sources of historical and concurrent data.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb2-1" title="1"><span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)</a></code></pre></div>
<pre><code>## [1] &quot;trial_A&quot;  &quot;trial_B&quot;  &quot;IIT&quot;      &quot;trial_AB&quot;</code></pre>
<div id="fitting-the-model" class="section level3">
<h3>Fitting the model</h3>
<p>To fit the hierarchical model described in [4], one makes a call to the function <code>blrm_exnex</code>, as below; although we slightly deviate from the model in [4] by allowing an EXchangeable/Non-EXchangeable prior for the drug components.</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb4-1" title="1"><span class="co">## Load involved packages</span></a>
<a class="sourceLine" id="cb4-2" title="2"><span class="kw">library</span>(RBesT)  <span class="co">## defines logit function</span></a>
<a class="sourceLine" id="cb4-3" title="3"><span class="kw">library</span>(dplyr)  <span class="co">## for mutate</span></a>
<a class="sourceLine" id="cb4-4" title="4"><span class="kw">library</span>(tidyr)  <span class="co">## defines crossing</span></a>
<a class="sourceLine" id="cb4-5" title="5"></a>
<a class="sourceLine" id="cb4-6" title="6"><span class="co">## Design parameters ---------------------</span></a>
<a class="sourceLine" id="cb4-7" title="7"></a>
<a class="sourceLine" id="cb4-8" title="8">dref &lt;-<span class="st"> </span><span class="kw">c</span>(<span class="dv">3</span>, <span class="dv">960</span>)</a>
<a class="sourceLine" id="cb4-9" title="9">num_comp &lt;-<span class="st"> </span><span class="dv">2</span> <span class="co"># two investigational drugs</span></a>
<a class="sourceLine" id="cb4-10" title="10">num_inter &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># one drug-drug interaction needs to be modeled</span></a>
<a class="sourceLine" id="cb4-11" title="11">num_groups &lt;-<span class="st"> </span><span class="kw">nlevels</span>(hist_combo2<span class="op">$</span>group_id) <span class="co"># four groups of data</span></a>
<a class="sourceLine" id="cb4-12" title="12">num_strata &lt;-<span class="st"> </span><span class="dv">1</span> <span class="co"># no stratification needed</span></a>
<a class="sourceLine" id="cb4-13" title="13"></a>
<a class="sourceLine" id="cb4-14" title="14"><span class="co">## abbreviate labels (wait for prior_summary)</span></a>
<a class="sourceLine" id="cb4-15" title="15"><span class="kw">options</span>(<span class="dt">OncoBayes2.abbreviate.min=</span><span class="dv">8</span>)</a>
<a class="sourceLine" id="cb4-16" title="16"></a>
<a class="sourceLine" id="cb4-17" title="17"><span class="co">## disables abbreviations (default)</span></a>
<a class="sourceLine" id="cb4-18" title="18"><span class="co">#options(OncoBayes2.abbreviate.min=0)</span></a>
<a class="sourceLine" id="cb4-19" title="19"></a>
<a class="sourceLine" id="cb4-20" title="20"><span class="co">## STRONGLY RECOMMENDED =&gt; uses 4 cores</span></a>
<a class="sourceLine" id="cb4-21" title="21"><span class="kw">options</span>(<span class="dt">mc.cores=</span><span class="dv">4</span>)</a>
<a class="sourceLine" id="cb4-22" title="22"></a>
<a class="sourceLine" id="cb4-23" title="23"><span class="co">## Model fit -----------------------------</span></a>
<a class="sourceLine" id="cb4-24" title="24"></a>
<a class="sourceLine" id="cb4-25" title="25">blrmfit &lt;-<span class="st"> </span><span class="kw">blrm_exnex</span>(</a>
<a class="sourceLine" id="cb4-26" title="26">  <span class="kw">cbind</span>(num_toxicities, num_patients <span class="op">-</span><span class="st"> </span>num_toxicities) <span class="op">~</span></a>
<a class="sourceLine" id="cb4-27" title="27"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_A <span class="op">/</span><span class="st"> </span>dref[<span class="dv">1</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-28" title="28"><span class="st">    </span><span class="dv">1</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(<span class="kw">log</span>(drug_B <span class="op">/</span><span class="st"> </span>dref[<span class="dv">2</span>])) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-29" title="29"><span class="st">    </span><span class="dv">0</span> <span class="op">+</span><span class="st"> </span><span class="kw">I</span>(drug_A<span class="op">/</span>dref[<span class="dv">1</span>] <span class="op">*</span><span class="st"> </span>drug_B<span class="op">/</span>dref[<span class="dv">2</span>]) <span class="op">|</span></a>
<a class="sourceLine" id="cb4-30" title="30"><span class="st">    </span>group_id,</a>
<a class="sourceLine" id="cb4-31" title="31">  <span class="dt">data =</span> hist_combo2,</a>
<a class="sourceLine" id="cb4-32" title="32">  <span class="dt">prior_EX_mu_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-33" title="33">    <span class="kw">c</span>(<span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>, <span class="co"># hyper-mean of (intercept, log-slope) for drug A</span></a>
<a class="sourceLine" id="cb4-34" title="34">      <span class="kw">logit</span>(<span class="fl">0.1</span>), <span class="dv">0</span>), <span class="co"># hyper-mean of (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-35" title="35">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-36" title="36">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-37" title="37">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-38" title="38">  ),</a>
<a class="sourceLine" id="cb4-39" title="39">  <span class="dt">prior_EX_mu_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-40" title="40">    <span class="kw">c</span>(<span class="fl">3.33</span>, <span class="dv">1</span>, <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-41" title="41">      <span class="fl">3.33</span>, <span class="dv">1</span>), <span class="co"># hyper-sd of mean mu for (intercept, log-slope) for drug B</span></a>
<a class="sourceLine" id="cb4-42" title="42">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-43" title="43">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-44" title="44">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-45" title="45">  ),</a>
<a class="sourceLine" id="cb4-46" title="46">  <span class="dt">prior_EX_tau_mean_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-47" title="47">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>),</a>
<a class="sourceLine" id="cb4-48" title="48">      <span class="kw">log</span>(<span class="fl">0.25</span>), <span class="kw">log</span>(<span class="fl">0.125</span>)),</a>
<a class="sourceLine" id="cb4-49" title="49">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-50" title="50">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-51" title="51">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-52" title="52">  ),</a>
<a class="sourceLine" id="cb4-53" title="53">  <span class="dt">prior_EX_tau_sd_comp =</span> <span class="kw">matrix</span>(</a>
<a class="sourceLine" id="cb4-54" title="54">    <span class="kw">c</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>,</a>
<a class="sourceLine" id="cb4-55" title="55">      <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>),</a>
<a class="sourceLine" id="cb4-56" title="56">    <span class="dt">nrow =</span> num_comp,</a>
<a class="sourceLine" id="cb4-57" title="57">    <span class="dt">ncol =</span> <span class="dv">2</span>,</a>
<a class="sourceLine" id="cb4-58" title="58">    <span class="dt">byrow =</span> <span class="ot">TRUE</span></a>
<a class="sourceLine" id="cb4-59" title="59">  ),</a>
<a class="sourceLine" id="cb4-60" title="60">  <span class="dt">prior_EX_mu_mean_inter =</span> <span class="dv">0</span>,</a>
<a class="sourceLine" id="cb4-61" title="61">  <span class="dt">prior_EX_mu_sd_inter =</span> <span class="fl">1.121</span>,</a>
<a class="sourceLine" id="cb4-62" title="62">  <span class="dt">prior_EX_tau_mean_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="fl">0.125</span>), <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-63" title="63">  <span class="dt">prior_EX_tau_sd_inter =</span> <span class="kw">matrix</span>(<span class="kw">log</span>(<span class="dv">4</span>) <span class="op">/</span><span class="st"> </span><span class="fl">1.96</span>, <span class="dt">nrow =</span> num_inter, <span class="dt">ncol =</span> num_strata),</a>
<a class="sourceLine" id="cb4-64" title="64">  <span class="dt">prior_is_EXNEX_comp =</span> <span class="kw">rep</span>(<span class="ot">TRUE</span>, num_comp),</a>
<a class="sourceLine" id="cb4-65" title="65">  <span class="dt">prior_is_EXNEX_inter =</span> <span class="kw">rep</span>(<span class="ot">FALSE</span>, num_inter),</a>
<a class="sourceLine" id="cb4-66" title="66">  <span class="co">## historical data is 100% EX</span></a>
<a class="sourceLine" id="cb4-67" title="67">  <span class="co">## new data only 80% EX</span></a>
<a class="sourceLine" id="cb4-68" title="68">  <span class="dt">prior_EX_prob_comp =</span> <span class="kw">matrix</span>(<span class="kw">c</span>(<span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-69" title="69">                                <span class="fl">1.0</span>, <span class="fl">1.0</span>,</a>
<a class="sourceLine" id="cb4-70" title="70">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>,</a>
<a class="sourceLine" id="cb4-71" title="71">                                <span class="fl">0.8</span>, <span class="fl">0.8</span>),</a>
<a class="sourceLine" id="cb4-72" title="72">                              <span class="dt">nrow =</span> num_groups,</a>
<a class="sourceLine" id="cb4-73" title="73">                              <span class="dt">ncol =</span> num_comp,</a>
<a class="sourceLine" id="cb4-74" title="74">                              <span class="dt">byrow=</span><span class="ot">TRUE</span>),</a>
<a class="sourceLine" id="cb4-75" title="75">  <span class="dt">prior_EX_prob_inter =</span> <span class="kw">matrix</span>(<span class="dv">1</span>, <span class="dt">nrow =</span> num_groups, <span class="dt">ncol =</span> num_inter),</a>
<a class="sourceLine" id="cb4-76" title="76">  <span class="dt">prior_tau_dist =</span> <span class="dv">1</span></a>
<a class="sourceLine" id="cb4-77" title="77">)</a></code></pre></div>
<p>The function <code>blrm_exnex</code> returns an object from which numerical and graphical posterior summaries can be extracted using OncoBayes2 functions. We recommend making use of the methods described below.</p>
</div>
<div id="summary-of-prior-specification" class="section level3">
<h3>Summary of prior specification</h3>
<p>The function <code>prior_summary</code> provides a facility for printing, in a readable format, a summary of the prior specification.</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb5-1" title="1"><span class="kw">prior_summary</span>(blrmfit) <span class="co"># not run here</span></a></code></pre></div>
</div>
<div id="summary-of-posterior" class="section level3">
<h3>Summary of posterior</h3>
<p>The main target of inference is generally the probability of DLT at a selection of possible doses. In order to obtain this inference, one needs to specify the covariate levels of interest (which need not be present in the observed data).</p>
<p>In this case, we are interested in predicitons for <code>trial_AB</code>, with the possible combination doses of drugs A and B below.</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb6-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">crossing</span>(</a>
<a class="sourceLine" id="cb6-2" title="2">  <span class="dt">group_id =</span> <span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>),</a>
<a class="sourceLine" id="cb6-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb6-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb6-5" title="5">)</a>
<a class="sourceLine" id="cb6-6" title="6">newdata<span class="op">$</span>group_id &lt;-<span class="st"> </span><span class="kw">factor</span>(newdata<span class="op">$</span>group_id, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id))</a></code></pre></div>
<p>Note it is important that the factor levels associated with <code>newdata$group_id</code> be consistent with the levels of the grouping factor used when calling <code>blrm_exnex</code>. In case you use <code>expand.grid</code>, then the <code>stringsAsFactors = FALSE</code> argument must be used to ensures that the variable will initially be treated as a character. We recommend using the <code>tidyr</code> command <code>crossing</code> which avoids casting strings to factors in an uncontrolled manner. The next line converts the <code>group_id</code> column to a factor with the correct set of four levels. Alternativley, we can create the <code>group_id</code> column directly as a <code>factor</code> column within <code>newdata</code>. The code below results in the same <code>newdata</code> in a more compact form.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb7-1" title="1">newdata &lt;-<span class="st"> </span><span class="kw">crossing</span>(</a>
<a class="sourceLine" id="cb7-2" title="2">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="kw">c</span>(<span class="st">&quot;trial_AB&quot;</span>), <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb7-3" title="3">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">3</span>, <span class="fl">4.5</span>, <span class="dv">6</span>),</a>
<a class="sourceLine" id="cb7-4" title="4">  <span class="dt">drug_B =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="dv">400</span>, <span class="dv">600</span>, <span class="dv">800</span>)</a>
<a class="sourceLine" id="cb7-5" title="5">)</a></code></pre></div>
<p>Posterior summary statistics for the DLT rates at these provisional doses can be extracted from the <code>blrmfit</code> object using the <code>summary</code> method.</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb8-1" title="1">summ_stats &lt;-<span class="st"> </span><span class="kw">summary</span>(blrmfit, </a>
<a class="sourceLine" id="cb8-2" title="2">                      <span class="dt">newdata =</span> newdata,</a>
<a class="sourceLine" id="cb8-3" title="3">                      <span class="dt">prob =</span> <span class="fl">0.95</span>,</a>
<a class="sourceLine" id="cb8-4" title="4">                      <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb8-5" title="5"></a>
<a class="sourceLine" id="cb8-6" title="6"><span class="kw">kable</span>(<span class="kw">cbind</span>(newdata, summ_stats), <span class="dt">digits =</span> <span class="dv">3</span>)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">0.0</td>
<td align="right">0</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">1.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">0.0</td>
<td align="right">400</td>
<td align="right">0.033</td>
<td align="right">0.043</td>
<td align="right">0.000</td>
<td align="right">0.020</td>
<td align="right">0.140</td>
<td align="right">0.983</td>
<td align="right">0.015</td>
<td align="right">0.002</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">0.0</td>
<td align="right">600</td>
<td align="right">0.063</td>
<td align="right">0.059</td>
<td align="right">0.004</td>
<td align="right">0.048</td>
<td align="right">0.209</td>
<td align="right">0.945</td>
<td align="right">0.048</td>
<td align="right">0.006</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">0.0</td>
<td align="right">800</td>
<td align="right">0.106</td>
<td align="right">0.075</td>
<td align="right">0.018</td>
<td align="right">0.089</td>
<td align="right">0.285</td>
<td align="right">0.835</td>
<td align="right">0.148</td>
<td align="right">0.016</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0</td>
<td align="right">0.052</td>
<td align="right">0.056</td>
<td align="right">0.000</td>
<td align="right">0.033</td>
<td align="right">0.205</td>
<td align="right">0.942</td>
<td align="right">0.056</td>
<td align="right">0.002</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.090</td>
<td align="right">0.083</td>
<td align="right">0.005</td>
<td align="right">0.065</td>
<td align="right">0.316</td>
<td align="right">0.849</td>
<td align="right">0.129</td>
<td align="right">0.022</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.127</td>
<td align="right">0.114</td>
<td align="right">0.010</td>
<td align="right">0.092</td>
<td align="right">0.437</td>
<td align="right">0.728</td>
<td align="right">0.206</td>
<td align="right">0.065</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.184</td>
<td align="right">0.157</td>
<td align="right">0.015</td>
<td align="right">0.135</td>
<td align="right">0.617</td>
<td align="right">0.570</td>
<td align="right">0.266</td>
<td align="right">0.163</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">0.090</td>
<td align="right">0.070</td>
<td align="right">0.007</td>
<td align="right">0.072</td>
<td align="right">0.265</td>
<td align="right">0.844</td>
<td align="right">0.150</td>
<td align="right">0.006</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.137</td>
<td align="right">0.118</td>
<td align="right">0.012</td>
<td align="right">0.102</td>
<td align="right">0.465</td>
<td align="right">0.696</td>
<td align="right">0.228</td>
<td align="right">0.076</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.185</td>
<td align="right">0.168</td>
<td align="right">0.012</td>
<td align="right">0.130</td>
<td align="right">0.656</td>
<td align="right">0.577</td>
<td align="right">0.250</td>
<td align="right">0.173</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.248</td>
<td align="right">0.225</td>
<td align="right">0.010</td>
<td align="right">0.173</td>
<td align="right">0.820</td>
<td align="right">0.473</td>
<td align="right">0.238</td>
<td align="right">0.288</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">0.153</td>
<td align="right">0.093</td>
<td align="right">0.024</td>
<td align="right">0.135</td>
<td align="right">0.373</td>
<td align="right">0.599</td>
<td align="right">0.352</td>
<td align="right">0.049</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">0.212</td>
<td align="right">0.170</td>
<td align="right">0.018</td>
<td align="right">0.162</td>
<td align="right">0.657</td>
<td align="right">0.494</td>
<td align="right">0.294</td>
<td align="right">0.212</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">0.265</td>
<td align="right">0.232</td>
<td align="right">0.011</td>
<td align="right">0.189</td>
<td align="right">0.831</td>
<td align="right">0.444</td>
<td align="right">0.237</td>
<td align="right">0.318</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">800</td>
<td align="right">0.324</td>
<td align="right">0.287</td>
<td align="right">0.007</td>
<td align="right">0.231</td>
<td align="right">0.937</td>
<td align="right">0.403</td>
<td align="right">0.201</td>
<td align="right">0.396</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">0</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">1.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400</td>
<td align="right">0.028</td>
<td align="right">0.027</td>
<td align="right">0.000</td>
<td align="right">0.020</td>
<td align="right">0.097</td>
<td align="right">0.999</td>
<td align="right">0.001</td>
<td align="right">0.000</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">600</td>
<td align="right">0.055</td>
<td align="right">0.036</td>
<td align="right">0.006</td>
<td align="right">0.050</td>
<td align="right">0.139</td>
<td align="right">0.990</td>
<td align="right">0.010</td>
<td align="right">0.000</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800</td>
<td align="right">0.098</td>
<td align="right">0.044</td>
<td align="right">0.029</td>
<td align="right">0.093</td>
<td align="right">0.197</td>
<td align="right">0.907</td>
<td align="right">0.093</td>
<td align="right">0.000</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">3.0</td>
<td align="right">0</td>
<td align="right">0.058</td>
<td align="right">0.072</td>
<td align="right">0.000</td>
<td align="right">0.032</td>
<td align="right">0.253</td>
<td align="right">0.917</td>
<td align="right">0.072</td>
<td align="right">0.011</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.090</td>
<td align="right">0.089</td>
<td align="right">0.005</td>
<td align="right">0.062</td>
<td align="right">0.340</td>
<td align="right">0.843</td>
<td align="right">0.130</td>
<td align="right">0.027</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.126</td>
<td align="right">0.113</td>
<td align="right">0.011</td>
<td align="right">0.090</td>
<td align="right">0.446</td>
<td align="right">0.732</td>
<td align="right">0.205</td>
<td align="right">0.062</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.182</td>
<td align="right">0.152</td>
<td align="right">0.017</td>
<td align="right">0.135</td>
<td align="right">0.595</td>
<td align="right">0.570</td>
<td align="right">0.278</td>
<td align="right">0.152</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">0.103</td>
<td align="right">0.102</td>
<td align="right">0.005</td>
<td align="right">0.073</td>
<td align="right">0.377</td>
<td align="right">0.801</td>
<td align="right">0.162</td>
<td align="right">0.037</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.143</td>
<td align="right">0.133</td>
<td align="right">0.010</td>
<td align="right">0.101</td>
<td align="right">0.520</td>
<td align="right">0.684</td>
<td align="right">0.222</td>
<td align="right">0.094</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.188</td>
<td align="right">0.174</td>
<td align="right">0.012</td>
<td align="right">0.129</td>
<td align="right">0.661</td>
<td align="right">0.575</td>
<td align="right">0.247</td>
<td align="right">0.178</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.251</td>
<td align="right">0.226</td>
<td align="right">0.010</td>
<td align="right">0.174</td>
<td align="right">0.812</td>
<td align="right">0.476</td>
<td align="right">0.229</td>
<td align="right">0.295</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">0.171</td>
<td align="right">0.147</td>
<td align="right">0.014</td>
<td align="right">0.130</td>
<td align="right">0.562</td>
<td align="right">0.594</td>
<td align="right">0.285</td>
<td align="right">0.121</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">0.222</td>
<td align="right">0.194</td>
<td align="right">0.016</td>
<td align="right">0.158</td>
<td align="right">0.738</td>
<td align="right">0.503</td>
<td align="right">0.264</td>
<td align="right">0.232</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">0.271</td>
<td align="right">0.243</td>
<td align="right">0.010</td>
<td align="right">0.187</td>
<td align="right">0.853</td>
<td align="right">0.457</td>
<td align="right">0.216</td>
<td align="right">0.327</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">6.0</td>
<td align="right">800</td>
<td align="right">0.329</td>
<td align="right">0.291</td>
<td align="right">0.006</td>
<td align="right">0.224</td>
<td align="right">0.943</td>
<td align="right">0.412</td>
<td align="right">0.179</td>
<td align="right">0.409</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">0.0</td>
<td align="right">0</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">1.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">0.0</td>
<td align="right">400</td>
<td align="right">0.068</td>
<td align="right">0.159</td>
<td align="right">0.000</td>
<td align="right">0.021</td>
<td align="right">0.715</td>
<td align="right">0.922</td>
<td align="right">0.028</td>
<td align="right">0.050</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">0.0</td>
<td align="right">600</td>
<td align="right">0.099</td>
<td align="right">0.169</td>
<td align="right">0.001</td>
<td align="right">0.049</td>
<td align="right">0.778</td>
<td align="right">0.885</td>
<td align="right">0.053</td>
<td align="right">0.062</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">0.0</td>
<td align="right">800</td>
<td align="right">0.141</td>
<td align="right">0.177</td>
<td align="right">0.001</td>
<td align="right">0.091</td>
<td align="right">0.831</td>
<td align="right">0.781</td>
<td align="right">0.140</td>
<td align="right">0.079</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">0</td>
<td align="right">0.100</td>
<td align="right">0.181</td>
<td align="right">0.000</td>
<td align="right">0.036</td>
<td align="right">0.820</td>
<td align="right">0.848</td>
<td align="right">0.081</td>
<td align="right">0.072</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.166</td>
<td align="right">0.229</td>
<td align="right">0.004</td>
<td align="right">0.077</td>
<td align="right">0.926</td>
<td align="right">0.730</td>
<td align="right">0.130</td>
<td align="right">0.141</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.201</td>
<td align="right">0.238</td>
<td align="right">0.008</td>
<td align="right">0.108</td>
<td align="right">0.936</td>
<td align="right">0.634</td>
<td align="right">0.188</td>
<td align="right">0.178</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.249</td>
<td align="right">0.251</td>
<td align="right">0.011</td>
<td align="right">0.155</td>
<td align="right">0.956</td>
<td align="right">0.510</td>
<td align="right">0.233</td>
<td align="right">0.257</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">0.147</td>
<td align="right">0.203</td>
<td align="right">0.003</td>
<td align="right">0.077</td>
<td align="right">0.907</td>
<td align="right">0.745</td>
<td align="right">0.152</td>
<td align="right">0.104</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.217</td>
<td align="right">0.248</td>
<td align="right">0.009</td>
<td align="right">0.119</td>
<td align="right">0.958</td>
<td align="right">0.598</td>
<td align="right">0.198</td>
<td align="right">0.203</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.258</td>
<td align="right">0.265</td>
<td align="right">0.009</td>
<td align="right">0.154</td>
<td align="right">0.969</td>
<td align="right">0.511</td>
<td align="right">0.220</td>
<td align="right">0.268</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.311</td>
<td align="right">0.289</td>
<td align="right">0.008</td>
<td align="right">0.203</td>
<td align="right">0.981</td>
<td align="right">0.433</td>
<td align="right">0.200</td>
<td align="right">0.366</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">0.210</td>
<td align="right">0.225</td>
<td align="right">0.006</td>
<td align="right">0.136</td>
<td align="right">0.946</td>
<td align="right">0.564</td>
<td align="right">0.260</td>
<td align="right">0.176</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">0.284</td>
<td align="right">0.272</td>
<td align="right">0.011</td>
<td align="right">0.188</td>
<td align="right">0.975</td>
<td align="right">0.453</td>
<td align="right">0.236</td>
<td align="right">0.311</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">0.327</td>
<td align="right">0.297</td>
<td align="right">0.008</td>
<td align="right">0.223</td>
<td align="right">0.986</td>
<td align="right">0.414</td>
<td align="right">0.198</td>
<td align="right">0.388</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">800</td>
<td align="right">0.376</td>
<td align="right">0.326</td>
<td align="right">0.005</td>
<td align="right">0.275</td>
<td align="right">0.992</td>
<td align="right">0.376</td>
<td align="right">0.170</td>
<td align="right">0.453</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">0</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
<td align="right">1.000</td>
<td align="right">0.000</td>
<td align="right">0.000</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">400</td>
<td align="right">0.065</td>
<td align="right">0.153</td>
<td align="right">0.000</td>
<td align="right">0.020</td>
<td align="right">0.698</td>
<td align="right">0.924</td>
<td align="right">0.029</td>
<td align="right">0.047</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">600</td>
<td align="right">0.097</td>
<td align="right">0.166</td>
<td align="right">0.001</td>
<td align="right">0.048</td>
<td align="right">0.785</td>
<td align="right">0.882</td>
<td align="right">0.061</td>
<td align="right">0.057</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">0.0</td>
<td align="right">800</td>
<td align="right">0.139</td>
<td align="right">0.177</td>
<td align="right">0.002</td>
<td align="right">0.089</td>
<td align="right">0.835</td>
<td align="right">0.782</td>
<td align="right">0.143</td>
<td align="right">0.075</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">0</td>
<td align="right">0.100</td>
<td align="right">0.181</td>
<td align="right">0.000</td>
<td align="right">0.036</td>
<td align="right">0.798</td>
<td align="right">0.849</td>
<td align="right">0.080</td>
<td align="right">0.072</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.164</td>
<td align="right">0.224</td>
<td align="right">0.004</td>
<td align="right">0.077</td>
<td align="right">0.919</td>
<td align="right">0.722</td>
<td align="right">0.143</td>
<td align="right">0.135</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">600</td>
<td align="right">0.200</td>
<td align="right">0.236</td>
<td align="right">0.008</td>
<td align="right">0.106</td>
<td align="right">0.942</td>
<td align="right">0.628</td>
<td align="right">0.194</td>
<td align="right">0.177</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800</td>
<td align="right">0.250</td>
<td align="right">0.252</td>
<td align="right">0.011</td>
<td align="right">0.152</td>
<td align="right">0.955</td>
<td align="right">0.518</td>
<td align="right">0.218</td>
<td align="right">0.264</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">0</td>
<td align="right">0.148</td>
<td align="right">0.203</td>
<td align="right">0.002</td>
<td align="right">0.078</td>
<td align="right">0.906</td>
<td align="right">0.741</td>
<td align="right">0.154</td>
<td align="right">0.106</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.217</td>
<td align="right">0.244</td>
<td align="right">0.009</td>
<td align="right">0.122</td>
<td align="right">0.954</td>
<td align="right">0.590</td>
<td align="right">0.204</td>
<td align="right">0.206</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600</td>
<td align="right">0.259</td>
<td align="right">0.264</td>
<td align="right">0.010</td>
<td align="right">0.153</td>
<td align="right">0.962</td>
<td align="right">0.516</td>
<td align="right">0.203</td>
<td align="right">0.281</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">800</td>
<td align="right">0.313</td>
<td align="right">0.290</td>
<td align="right">0.009</td>
<td align="right">0.200</td>
<td align="right">0.976</td>
<td align="right">0.431</td>
<td align="right">0.201</td>
<td align="right">0.368</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">0</td>
<td align="right">0.212</td>
<td align="right">0.225</td>
<td align="right">0.004</td>
<td align="right">0.138</td>
<td align="right">0.942</td>
<td align="right">0.561</td>
<td align="right">0.255</td>
<td align="right">0.184</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400</td>
<td align="right">0.286</td>
<td align="right">0.268</td>
<td align="right">0.012</td>
<td align="right">0.186</td>
<td align="right">0.973</td>
<td align="right">0.450</td>
<td align="right">0.232</td>
<td align="right">0.318</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">600</td>
<td align="right">0.331</td>
<td align="right">0.297</td>
<td align="right">0.009</td>
<td align="right">0.222</td>
<td align="right">0.983</td>
<td align="right">0.413</td>
<td align="right">0.193</td>
<td align="right">0.394</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">800</td>
<td align="right">0.380</td>
<td align="right">0.328</td>
<td align="right">0.006</td>
<td align="right">0.274</td>
<td align="right">0.991</td>
<td align="right">0.376</td>
<td align="right">0.170</td>
<td align="right">0.454</td>
</tr>
</tbody>
</table>
<p>Such summaries may be used to assess which combination doses have acceptable risk of toxicity. For example, according the escalation with overdose control (EWOC) design criteria [3], any doses for which the last column does not exceed 25% are eligible for enrollment.</p>
</div>
<div id="data-scenarios" class="section level3">
<h3>Data scenarios</h3>
<p>Before <code>trial_AB</code> is initiated, it may be of interest to test how this model responds in various scenarios for the initial combination cohort(s).</p>
<p>This can be done easily in OncoBayes2 by updating the initial model fit with additional rows of hypothetical data. In the code below, we explore 3 possible outcomes for an initial cohort enrolled at 3 mg Drug A + 400 mg Drug B, and review the model’s inference at adjacent doses. Note that the <code>update</code> method for accepts an <code>add_data</code> argument which appends the additional data to the existing data of the previous analysis.</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb9-1" title="1"><span class="co"># set up two scenarios at the starting dose level</span></a>
<a class="sourceLine" id="cb9-2" title="2"><span class="co"># store them as data frames in a named list</span></a>
<a class="sourceLine" id="cb9-3" title="3">scenarios &lt;-<span class="st"> </span><span class="kw">crossing</span>(</a>
<a class="sourceLine" id="cb9-4" title="4">  <span class="dt">group_id  =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-5" title="5">  <span class="dt">drug_A =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-6" title="6">  <span class="dt">drug_B =</span> <span class="dv">400</span>,</a>
<a class="sourceLine" id="cb9-7" title="7">  <span class="dt">num_patients      =</span> <span class="dv">3</span>,</a>
<a class="sourceLine" id="cb9-8" title="8">  <span class="dt">num_toxicities      =</span> <span class="dv">1</span><span class="op">:</span><span class="dv">2</span></a>
<a class="sourceLine" id="cb9-9" title="9">) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">split</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>) <span class="op">%&gt;%</span><span class="st"> </span><span class="kw">setNames</span>(<span class="kw">paste</span>(<span class="dv">1</span><span class="op">:</span><span class="dv">2</span>, <span class="st">&quot;DLTs&quot;</span>))</a>
<a class="sourceLine" id="cb9-10" title="10"></a>
<a class="sourceLine" id="cb9-11" title="11">candidate_doses &lt;-<span class="st"> </span><span class="kw">crossing</span>(</a>
<a class="sourceLine" id="cb9-12" title="12">  <span class="dt">group_id =</span> <span class="kw">factor</span>(<span class="st">&quot;trial_AB&quot;</span>, <span class="kw">levels</span>(hist_combo2<span class="op">$</span>group_id)),</a>
<a class="sourceLine" id="cb9-13" title="13">  <span class="dt">drug_A =</span> <span class="kw">c</span>(<span class="dv">3</span>, <span class="fl">4.5</span>),</a>
<a class="sourceLine" id="cb9-14" title="14">  <span class="dt">drug_B =</span> <span class="dv">400</span></a>
<a class="sourceLine" id="cb9-15" title="15">)</a>
<a class="sourceLine" id="cb9-16" title="16"></a>
<a class="sourceLine" id="cb9-17" title="17">scenario_inference &lt;-<span class="st"> </span><span class="kw">lapply</span>(scenarios, <span class="cf">function</span>(scenario_newdata){</a>
<a class="sourceLine" id="cb9-18" title="18">  </a>
<a class="sourceLine" id="cb9-19" title="19">  <span class="co"># refit the model with each scenario&#39;s additional data</span></a>
<a class="sourceLine" id="cb9-20" title="20">  scenario_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">add_data =</span> scenario_newdata)</a>
<a class="sourceLine" id="cb9-21" title="21">  </a>
<a class="sourceLine" id="cb9-22" title="22">  <span class="co"># summarize posterior at candidate doses</span></a>
<a class="sourceLine" id="cb9-23" title="23">  scenario_summ &lt;-<span class="st"> </span><span class="kw">summary</span>(scenario_fit,</a>
<a class="sourceLine" id="cb9-24" title="24">                           <span class="dt">newdata =</span> candidate_doses,</a>
<a class="sourceLine" id="cb9-25" title="25">                           <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="dv">1</span>))</a>
<a class="sourceLine" id="cb9-26" title="26">  </a>
<a class="sourceLine" id="cb9-27" title="27">  <span class="kw">cbind</span>(candidate_doses, scenario_summ)</a>
<a class="sourceLine" id="cb9-28" title="28">  </a>
<a class="sourceLine" id="cb9-29" title="29">})</a></code></pre></div>
<table>
<caption>Model inference when 1 DLT is observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.201</td>
<td align="right">0.095</td>
<td align="right">0.062</td>
<td align="right">0.186</td>
<td align="right">0.424</td>
<td align="right">0.377</td>
<td align="right">0.521</td>
<td align="right">0.102</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.286</td>
<td align="right">0.136</td>
<td align="right">0.077</td>
<td align="right">0.268</td>
<td align="right">0.595</td>
<td align="right">0.188</td>
<td align="right">0.477</td>
<td align="right">0.336</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.206</td>
<td align="right">0.106</td>
<td align="right">0.056</td>
<td align="right">0.187</td>
<td align="right">0.460</td>
<td align="right">0.392</td>
<td align="right">0.489</td>
<td align="right">0.120</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.298</td>
<td align="right">0.152</td>
<td align="right">0.073</td>
<td align="right">0.276</td>
<td align="right">0.641</td>
<td align="right">0.193</td>
<td align="right">0.438</td>
<td align="right">0.368</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.253</td>
<td align="right">0.187</td>
<td align="right">0.032</td>
<td align="right">0.209</td>
<td align="right">0.897</td>
<td align="right">0.328</td>
<td align="right">0.460</td>
<td align="right">0.212</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.341</td>
<td align="right">0.211</td>
<td align="right">0.050</td>
<td align="right">0.298</td>
<td align="right">0.944</td>
<td align="right">0.180</td>
<td align="right">0.390</td>
<td align="right">0.430</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.258</td>
<td align="right">0.195</td>
<td align="right">0.038</td>
<td align="right">0.208</td>
<td align="right">0.899</td>
<td align="right">0.337</td>
<td align="right">0.440</td>
<td align="right">0.224</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.345</td>
<td align="right">0.218</td>
<td align="right">0.050</td>
<td align="right">0.296</td>
<td align="right">0.945</td>
<td align="right">0.189</td>
<td align="right">0.378</td>
<td align="right">0.433</td>
</tr>
</tbody>
</table>
<table>
<caption>Model inference when 2 DLTs are observed in first cohort</caption>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">mean</th>
<th align="right">sd</th>
<th align="right">2.5%</th>
<th align="right">50%</th>
<th align="right">97.5%</th>
<th align="right">(0,0.16]</th>
<th align="right">(0.16,0.33]</th>
<th align="right">(0.33,1]</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.377</td>
<td align="right">0.123</td>
<td align="right">0.154</td>
<td align="right">0.372</td>
<td align="right">0.636</td>
<td align="right">0.029</td>
<td align="right">0.340</td>
<td align="right">0.632</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.503</td>
<td align="right">0.152</td>
<td align="right">0.202</td>
<td align="right">0.509</td>
<td align="right">0.784</td>
<td align="right">0.011</td>
<td align="right">0.129</td>
<td align="right">0.860</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.415</td>
<td align="right">0.145</td>
<td align="right">0.161</td>
<td align="right">0.402</td>
<td align="right">0.729</td>
<td align="right">0.025</td>
<td align="right">0.268</td>
<td align="right">0.707</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.545</td>
<td align="right">0.167</td>
<td align="right">0.210</td>
<td align="right">0.547</td>
<td align="right">0.854</td>
<td align="right">0.010</td>
<td align="right">0.101</td>
<td align="right">0.889</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.450</td>
<td align="right">0.203</td>
<td align="right">0.070</td>
<td align="right">0.431</td>
<td align="right">0.958</td>
<td align="right">0.065</td>
<td align="right">0.207</td>
<td align="right">0.728</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.568</td>
<td align="right">0.212</td>
<td align="right">0.107</td>
<td align="right">0.575</td>
<td align="right">0.982</td>
<td align="right">0.042</td>
<td align="right">0.091</td>
<td align="right">0.867</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400</td>
<td align="right">0.444</td>
<td align="right">0.202</td>
<td align="right">0.061</td>
<td align="right">0.426</td>
<td align="right">0.947</td>
<td align="right">0.068</td>
<td align="right">0.215</td>
<td align="right">0.718</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">400</td>
<td align="right">0.564</td>
<td align="right">0.211</td>
<td align="right">0.099</td>
<td align="right">0.573</td>
<td align="right">0.978</td>
<td align="right">0.041</td>
<td align="right">0.090</td>
<td align="right">0.869</td>
</tr>
</tbody>
</table>
</div>
</div>
<div id="continuation-of-example" class="section level2">
<h2>Continuation of example</h2>
<p>In the example of [1], at the time of completion of <code>trial_AB</code>, the complete historical and concurrent data are as follows.</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb10-1" title="1"><span class="kw">kable</span>(codata_combo2)</a></code></pre></div>
<table>
<thead>
<tr class="header">
<th align="left">group_id</th>
<th align="right">drug_A</th>
<th align="right">drug_B</th>
<th align="right">num_patients</th>
<th align="right">num_toxicities</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">3.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">4.5</td>
<td align="right">0.0</td>
<td align="right">6</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_A</td>
<td align="right">6.0</td>
<td align="right">0.0</td>
<td align="right">11</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_A</td>
<td align="right">8.0</td>
<td align="right">0.0</td>
<td align="right">3</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">33.3</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">50.0</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">100.0</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">200.0</td>
<td align="right">9</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">400.0</td>
<td align="right">15</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">800.0</td>
<td align="right">20</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">trial_B</td>
<td align="right">0.0</td>
<td align="right">1120.0</td>
<td align="right">17</td>
<td align="right">4</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">7</td>
<td align="right">5</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">4.5</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr class="odd">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">6</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">IIT</td>
<td align="right">6.0</td>
<td align="right">600.0</td>
<td align="right">3</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">400.0</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">3.0</td>
<td align="right">800.0</td>
<td align="right">6</td>
<td align="right">2</td>
</tr>
<tr class="odd">
<td align="left">trial_AB</td>
<td align="right">4.5</td>
<td align="right">600.0</td>
<td align="right">10</td>
<td align="right">2</td>
</tr>
<tr class="even">
<td align="left">trial_AB</td>
<td align="right">6.0</td>
<td align="right">400.0</td>
<td align="right">10</td>
<td align="right">3</td>
</tr>
</tbody>
</table>
<p>Numerous toxicities were observed in the concurrent <code>IIT</code> study. Through the MAC framework, these data can influence the model summaries for <code>trial_AB</code>. Note that we use the <code>update</code> function differently than before, since we specify the entire data-set now we use the <code>data</code> argument.</p>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb11-1" title="1">final_fit &lt;-<span class="st"> </span><span class="kw">update</span>(blrmfit, <span class="dt">data =</span> codata_combo2)</a>
<a class="sourceLine" id="cb11-2" title="2"></a>
<a class="sourceLine" id="cb11-3" title="3">summ &lt;-<span class="st"> </span><span class="kw">summary</span>(final_fit, newdata, <span class="dt">prob =</span> <span class="kw">c</span>(<span class="fl">0.5</span>, <span class="fl">0.95</span>), <span class="dt">interval_prob =</span> <span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.33</span>,<span class="dv">1</span>))</a>
<a class="sourceLine" id="cb11-4" title="4"></a>
<a class="sourceLine" id="cb11-5" title="5">final_summ_stats &lt;-<span class="st"> </span><span class="kw">cbind</span>(newdata, summ) <span class="op">%&gt;%</span></a>
<a class="sourceLine" id="cb11-6" title="6"><span class="st">    </span><span class="kw">mutate</span>(<span class="dt">EWOC=</span><span class="dv">1</span><span class="op">*</span><span class="st">`</span><span class="dt">(0.33,1]</span><span class="st">`</span><span class="op">&lt;=</span><span class="fl">0.25</span>)</a></code></pre></div>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb12-1" title="1"><span class="kw">ggplot</span>(final_summ_stats,</a>
<a class="sourceLine" id="cb12-2" title="2">       <span class="kw">aes</span>(<span class="dt">x=</span><span class="kw">factor</span>(drug_B), <span class="dt">colour=</span>EWOC)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-3" title="3"><span class="st">    </span><span class="kw">facet_wrap</span>(<span class="op">~</span>drug_A, <span class="dt">labeller=</span>label_both) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-4" title="4"><span class="st">    </span><span class="kw">scale_y_continuous</span>(<span class="dt">breaks=</span><span class="kw">c</span>(<span class="dv">0</span>, <span class="fl">0.16</span>, <span class="fl">0.33</span>, <span class="fl">0.4</span>, <span class="fl">0.6</span>, <span class="fl">0.8</span>, <span class="fl">1.0</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-5" title="5"><span class="st">    </span><span class="kw">coord_cartesian</span>(<span class="dt">ylim=</span><span class="kw">c</span>(<span class="dv">0</span>,<span class="fl">0.8</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-6" title="6"><span class="st">    </span><span class="kw">geom_hline</span>(<span class="dt">yintercept =</span> <span class="kw">c</span>(<span class="fl">0.16</span>, <span class="fl">0.33</span>),</a>
<a class="sourceLine" id="cb12-7" title="7">               <span class="dt">linetype =</span> <span class="st">&quot;dotted&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-8" title="8"><span class="st">    </span><span class="kw">geom_pointrange</span>(<span class="kw">aes</span>(<span class="dt">y=</span><span class="st">`</span><span class="dt">50%</span><span class="st">`</span>, <span class="dt">ymin=</span><span class="st">`</span><span class="dt">2.5%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">97.5%</span><span class="st">`</span>)) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-9" title="9"><span class="st">    </span><span class="kw">geom_linerange</span>(<span class="kw">aes</span>(<span class="dt">ymin=</span><span class="st">`</span><span class="dt">25%</span><span class="st">`</span>, <span class="dt">ymax=</span><span class="st">`</span><span class="dt">75%</span><span class="st">`</span>), <span class="dt">size=</span><span class="fl">1.5</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-10" title="10"><span class="st">    </span><span class="kw">ggtitle</span>(<span class="st">&quot;DLT Probability&quot;</span>, <span class="st">&quot;Shown is the median (dot), 50% CrI (thick line) and 95% CrI (thin line)&quot;</span>) <span class="op">+</span></a>
<a class="sourceLine" id="cb12-11" title="11"><span class="st">    </span><span class="kw">ylab</span>(<span class="ot">NULL</span>) <span class="op">+</span><span class="st"> </span></a>
<a class="sourceLine" id="cb12-12" title="12"><span class="st">    </span><span class="kw">xlab</span>(<span class="st">&quot;Dose Drug B [mg]&quot;</span>)</a></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<p>[1] Neuenschwander, B., Roychoudhury, S., &amp; Schmidli, H. (2016). On the use of co-data in clinical trials. Statistics in Biopharmaceutical Research, 8(3), 345-354.</p>
<p>[2] Neuenschwander, B., Wandel, S., Roychoudhury, S., &amp; Bailey, S. (2016). Robust exchangeability designs for early phase clinical trials with multiple strata. Pharmaceutical statistics, 15(2), 123-134.</p>
<p>[3] Neuenschwander, B., Branson, M., &amp; Gsponer, T. (2008). Critical aspects of the Bayesian approach to phase I cancer trials. Statistics in medicine, 27(13), 2420-2439.</p>
<p>[4] Neuenschwander, B., Matano, A., Tang, Z., Roychoudhury, S., Wandel, S. Bailey, Stuart. (2014). A Bayesian Industry Approach to Phase I Combination Trials in Oncology. In Statistical methods in drug combination studies (Vol. 69). CRC Press.</p>
</div>
<div id="session-info" class="section level2">
<h2>Session Info</h2>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><a class="sourceLine" id="cb13-1" title="1"><span class="kw">sessionInfo</span>()</a></code></pre></div>
<pre><code>## R version 3.6.1 (2019-07-05)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 16.04.6 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/libblas/libblas.so.3.6.0
## LAPACK: /usr/lib/lapack/liblapack.so.3.6.0
## 
## locale:
## [1] C
## 
## attached base packages:
## [1] stats     graphics  grDevices utils     datasets  methods   base     
## 
## other attached packages:
## [1] tidyr_1.0.0      dplyr_0.8.3      RBesT_1.4-0      ggplot2_3.2.1   
## [5] knitr_1.25       OncoBayes2_0.5-3 Rcpp_1.0.2      
## 
## loaded via a namespace (and not attached):
##  [1] rstan_2.19.2       tidyselect_0.2.5   xfun_0.10         
##  [4] purrr_0.3.3        colorspace_1.4-1   vctrs_0.2.0       
##  [7] htmltools_0.4.0    stats4_3.6.1       loo_2.1.0         
## [10] yaml_2.2.0         rlang_0.4.0        pkgbuild_1.0.6    
## [13] pillar_1.4.2       withr_2.1.2        glue_1.3.1        
## [16] matrixStats_0.55.0 lifecycle_0.1.0    plyr_1.8.4        
## [19] stringr_1.4.0      munsell_0.5.0      gtable_0.3.0      
## [22] mvtnorm_1.0-11     codetools_0.2-16   evaluate_0.14     
## [25] inline_0.3.15      callr_3.3.2        ps_1.3.0          
## [28] parallel_3.6.1     bayesplot_1.7.0    highr_0.8         
## [31] rstantools_2.0.0   scales_1.0.0       backports_1.1.5   
## [34] checkmate_1.9.4    StanHeaders_2.19.0 abind_1.4-5       
## [37] gridExtra_2.3      digest_0.6.21      stringi_1.4.3     
## [40] processx_3.4.1     grid_3.6.1         cli_1.1.0         
## [43] tools_3.6.1        magrittr_1.5       lazyeval_0.2.2    
## [46] tibble_2.1.3       Formula_1.2-3      crayon_1.3.4      
## [49] pkgconfig_2.0.3    zeallot_0.1.0      ellipsis_0.3.0    
## [52] prettyunits_1.0.2  ggridges_0.5.1     assertthat_0.2.1  
## [55] rmarkdown_1.16     R6_2.4.0           compiler_3.6.1</code></pre>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
